Proposed role of primary protein carbonylation in cell signaling

Redox Report

Volumn 17, Issue 2, 2012, Pages 90-94

  Wong, Chi Ming ^a   Bansal, Geetanjali ^a   Marcocci, Lucia ^b   Suzuki, Yuichiro J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Carbonylation; Cell signaling; Reactive oxygen species; Redox signaling

Indexed keywords

4 HYDROXYNONENAL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR GATA 4;

ARTICLE; CELL LYSATE; DENSITOMETRY; GENETIC TRANSCRIPTION; HEART VENTRICLE HYPERTROPHY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; PROTEIN STRUCTURE; WESTERN BLOTTING;

EID: 84861130344     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000007     Document Type: Article

References (21)

1. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269-85.
2. Suzuki YJ, Carini M, Butterfield DA. Protein carbonylation. Antioxid Redox Signal 2010;12:323-5.
3. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005;24:1311-7.
4. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169-76.
5. Requena JR, Chao CC, Levine RL, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001;98:69-74.
6. Ellis EM. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther 2007;115:13-24.
7. Madian AG, Regnier FE. Proteomic identification of carbonylated proteins and their oxidation sites. J Proteome Res 2010;9: 3766-80.
8. Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002;32:790-6.
9. Wong CM, Cheema AK, Zhang L, Suzuki YJ. Protein carbonylation as a novel mechanism in redox signaling. Circ Res 2008; 102:310-8.
10. Park AM, Wong CM, Jelinkova L, Liu L, Nagase H, Suzuki YJ. Pulmonary hypertension-induced GATA4 activation in the right ventricle. Hypertension 2010;56:1145-51.
11. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H2O2 accumulation for cell signaling. Cell 2010;140: 517-28.
12. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-57.
13. Dalle-Donne I, Carini M, Orioli M, Vistoli G, Regazzoni L, Colombo G, et al. Protein carbonylation: 2,4-dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids. Free Radic Biol Med 2009;46:1411-9.
14. Yoo BS, Regnier FE. Proteomic analysis of carbonylated proteins in two-dimensional gel electrophoresis using avidin-fluorescein affinity staining. Electrophoresis 2004;25:1334-41.
15. Aoyama Y, Motokawa Y. L-Threonine dehydrogenase of chicken liver. Purification, characterization, and physiological significance. J Biol Chem 1981;256:12367-73.
16. Marcus JP, Dekker EE. Threonine formation via the coupled activity of 2-amino-3-ketobutyrate coenzyme A lyase and threonine dehydrogenase. J Bacteriol 1993;175:6505-11.
17. Jones EE, Broquist HP. Saccharopine, an intermediate of the aminoadipic acid pathway of lysine biosynthesis. 3. Aminoadipic semialdehyde-glutamate reductase. J Biol Chem 1966;241: 3430-4.
18. Saunders PP, Broquist HP. Saccharopine, an intermediate of the aminoadipic acid pathway of lysine biosynthesis. IV. Saccharopine dehydrogenase. J Biol Chem 1966;241: 3435-40.
19. Smith ME, Greenberg DM. Characterization of an enzyme reducing pyrroline-5-carboxylate to proline. Nature 1956;177: 1130.
20. Scarpulla RC, Soffer RL. Membrane-bound proline dehydrogenase from Escherichia coli Solubilization, purification, and characterization. J Biol Chem 1978;253:5997-6001.
21. Seiler N. Ornithine aminotransferase, a potential target for thetreatment of hyperammonemias. Curr Drug Targets 2000;1: 119-53.